132 related articles for article (PubMed ID: 37565528)
21. Evaluation of Unfractionated Heparin Dosing by Antifactor Xa During Targeted Temperature Management Post Cardiac Arrest.
Belcher C; Kataria V; Ryman KM; Wang X; Moon JY; Modrykamien A; Mora A
Hosp Pharm; 2022 Aug; 57(4):504-509. PubMed ID: 35898262
[TBL] [Abstract][Full Text] [Related]
22. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
Glick D; Dzierba AL; Abrams D; Muir J; Eisenberger A; Diuguid D; Abel E; Agerstrand C; Bacchetta M; Brodie D
J Crit Care; 2015 Dec; 30(6):1190-4. PubMed ID: 26363901
[TBL] [Abstract][Full Text] [Related]
23. Conversion From Activated Clotting Time to Anti-Xa Heparin Activity Assay for Heparin Monitoring During Extracorporeal Membrane Oxygenation.
Figueroa Villalba CA; Brogan TV; McMullan DM; Yalon L; Jordan DI; Chandler WL
Crit Care Med; 2020 Dec; 48(12):e1179-e1184. PubMed ID: 33009103
[TBL] [Abstract][Full Text] [Related]
24. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
Dager WE; Gosselin RC; Yoshikawa R; Owings JT
Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
[TBL] [Abstract][Full Text] [Related]
25. The Influence of Haemostatic System Maturation on the Dose-Response Relationship of Unfractionated Heparin.
Derbalah A; Duffull S; Moynihan K; Al-Sallami H
Clin Pharmacokinet; 2021 Apr; 60(4):491-499. PubMed ID: 33128209
[TBL] [Abstract][Full Text] [Related]
26. Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review.
Geli J; Capoccia M; Maybauer DM; Maybauer MO
J Intensive Care Med; 2022 Apr; 37(4):459-471. PubMed ID: 33653194
[TBL] [Abstract][Full Text] [Related]
27. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.
Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS
Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569
[TBL] [Abstract][Full Text] [Related]
28. Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
Ryerson LM; Balutis KR; Granoski DA; Nelson LR; Massicotte MP; Lequier LL; Bauman ME
Pediatr Crit Care Med; 2020 Nov; 21(11):975-985. PubMed ID: 32976347
[TBL] [Abstract][Full Text] [Related]
29. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels.
Dingus SJ; Smith AR; Dager WE; Zochert S; Nothdurft SA; Gulseth MP
Ann Pharmacother; 2022 Dec; 56(12):1289-1298. PubMed ID: 35499336
[TBL] [Abstract][Full Text] [Related]
31. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
Ignjatovic V; Summerhayes R; Gan A; Than J; Chan A; Cochrane A; Bennett M; Horton S; Shann F; Lane G; Ross-Smith M; Monagle P
Thromb Res; 2007; 120(3):347-51. PubMed ID: 17118432
[TBL] [Abstract][Full Text] [Related]
32. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
[TBL] [Abstract][Full Text] [Related]
33. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
Diaz D; Martinez J; Bushman G; Wolowich WR
J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
[TBL] [Abstract][Full Text] [Related]
34. Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
Nguyen TP; Phan XT; Huynh DQ; Viet Truong HT; Hai Le YN; Nguyen TM; Minh Du QQ; Le TP; Truong HN; Ho TT; Ngoc Pham TT
Crit Care Res Pract; 2021; 2021():5579936. PubMed ID: 34055407
[TBL] [Abstract][Full Text] [Related]
35. Bivalirudin in pediatric extracorporeal membrane oxygenation.
Ryerson LM; McMichael ABV
Curr Opin Pediatr; 2022 Jun; 34(3):255-260. PubMed ID: 35634698
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of a Calculation-Free Weight-Based Unfractionated Heparin Nomogram With Anti-Xa Level Monitoring Compared With Activated Partial Thromboplastin Time.
Kindelin NM; Anthes AM; Providence SM; Zhao X; Aspinall SL
Ann Pharmacother; 2021 May; 55(5):575-583. PubMed ID: 32964730
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation.
Sheridan EA; Sekela ME; Pandya KA; Schadler A; Ather A
ASAIO J; 2022 Jul; 68(7):920-924. PubMed ID: 34669620
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients.
Northam KA; Nguyen B; Chen SL; Sredzienski E; Charles A
J Pharm Pract; 2023 Feb; 36(1):79-86. PubMed ID: 34109859
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
[TBL] [Abstract][Full Text] [Related]
40. Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients.
Gratz J; Pausch A; Schaden E; Baierl A; Jaksch P; Erhart F; Hoetzenecker K; Wiegele M
Artif Organs; 2020 Jun; 44(6):638-646. PubMed ID: 31951030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
